MRI-based prediction of DNA methylation grade in IDH-mutant astrocytomas using qualitative imaging features and tumor volumetrics

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Neuroradiology

• Publication date

  2025-11-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00234-025-03766-zPMID 41217503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ten Years of VASARI Glioma Features: Systematic Review and Meta-Analysis of Their Impact and Performance

  2024cited by this paper
• T2-FLAIR mismatch sign predicts DNA methylation subclass and CDKN2A/B status in IDH-mutant astrocytomas.

  2024cited by this paper
• Presurgical diagnosis of diffuse gliomas in adults: Post-WHO 2021 practical perspectives from radiologists in neuro-oncology units.

  2024influential reference
• Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.

  2024cited by this paper
• Beyond invasive biopsies: using VASARI MRI features to predict grade and molecular parameters in gliomas

  2024cited by this paper
• Peritumoral Edema in Gliomas: A Review of Mechanisms and Management

  2023cited by this paper
• Federated learning enables big data for rare cancer boundary detection

  2022cited by this paper
• The imaging features and prognosis of gliomas involving the subventricular zone: An MRI study.

  2022influential reference
• Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas

  2022cited by this paper
• DNA methylation as a diagnostic tool

  2022cited by this paper
• Necrotic reshaping of the glioma microenvironment drives disease progression

  2022cited by this paper
• Spatial concordance of DNA methylation classification in diffuse glioma

  2021influential reference
• The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

  2021cited by this paper
• Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research

  2019cited by this paper
• Whole Genome DNA Methylation Analysis of Human Glioblastoma Using Illumina BeadArrays.

  2018cited by this paper
• Novel, improved grading system(s) for IDH-mutant astrocytic gliomas

  2018cited by this paper
• DNA methylation-based classification of central nervous system tumours

  2018cited by this paper
• Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas

  2018cited by this paper
• Amplification of distinct α-synuclein fibril conformers through protein misfolding cyclic amplification

  2017cited by this paper
• Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging

  2015cited by this paper
• Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

  2015cited by this paper
• IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO

  2015cited by this paper
• IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas

  2015cited by this paper
• MR imaging correlates of survival in patients with high-grade gliomas.

  2005cited by this paper
• SMOTE: Synthetic Minority Over-sampling Technique

  2002cited by this paper

• No citing papers are available for this paper.